Clinical Trial Update: To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI) [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed pharmacokinetics and safety of a fixed-dose inhaled combination of fluticasone furoate and umeclidinium compared with the individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone furoate/umeclidinium (fluticasone furoate/umeclidinium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED